Cargando…

No Impact of Vitamin D on the CYP3A Biomarker 4β-Hydroxycholesterol in Patients with Abnormal Glucose Regulation

PURPOSE: To investigate the effect of vitamin D3 on hepatic Cytochrome P450 enzyme (CYP) 3A4 in patients with abnormal glucose regulation using the endogenous marker 4β-hydroxycholesterol (4β-OHC):cholesterol ratio. METHODS: The present study took advantage of a trial primarily aiming to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mannheimer, Buster, Wagner, Henrik, Östenson, Claes-Göran, Diczfalusy, Ulf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383380/ https://www.ncbi.nlm.nih.gov/pubmed/25835492 http://dx.doi.org/10.1371/journal.pone.0121984

Ejemplares similares

Pregnancy Increases CYP3A Enzymes Activity as Measured by the 4β-Hydroxycholesterol/Cholesterol Ratio
por: Mlugu, Eulambius M., et al.
Publicado: (2022)

CYP3A Activity in End-of-Life Cancer Patients Measured by 4β-Hydroxycholesterol/cholesterol Ratio, in Men and Women
por: Bergström, Helena, et al.
Publicado: (2021)

Fasting plasma glucose and serum 25-hydroxy vitamin D levels in individuals with Middle Eastern and Swedish descent
por: Taloyan, Marina, et al.
Publicado: (2023)

Inverse association between glucose-lowering medications and severe hyponatremia: a Swedish population-based case-control study
por: Falhammar, Henrik, et al.
Publicado: (2019)

Studies on CYP3A activity during the menstrual cycle as measured by urinary 6β‐hydroxycortisol/cortisol
por: Bergström, Helena, et al.
Publicado: (2021)

Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug–Drug Interaction in Healthy Volunteers
por: Li, Xue-Qing, et al.
Publicado: (2021)

24S-hydroxycholesterol and 25-hydroxycholesterol differentially impact hippocampal neuronal survival following oxygen-glucose deprivation
por: Sun, Min-Yu, et al.
Publicado: (2017)

Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatment
por: Li, Yan, et al.
Publicado: (2019)

Clinical Evaluation Based on a New Approach to Improve the Accuracy of 4β-Hydroxycholesterol Measurement as a Biomarker of CYP3A4 Activity
por: Taya, Yuki, et al.
Publicado: (2023)

Formation of CYP3A‐specific metabolites of ibrutinib in vitro is correlated with hepatic CYP3A activity and 4β‐hydroxycholesterol/cholesterol ratio
por: Lee, Jonghwa, et al.
Publicado: (2022)

Excitotoxicity increases the release of 24S-hydroxycholesterol via CYP46A1 activation
por: Sodero, Alejandro, et al.
Publicado: (2013)

Evaluation of 4β-Hydroxycholesterol as a Clinical Biomarker of CYP3A4 Drug Interactions Using a Bayesian Mechanism–Based Pharmacometric Model
por: Leil, T A, et al.
Publicado: (2014)

Mortality in Patients With Nonfunctional Adrenal Tumors
por: Patrova, Jekaterina, et al.
Publicado: (2023)

Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time
por: Tung, Norint P., et al.
Publicado: (2022)

Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort
por: Le Cornet, Charlotte, et al.
Publicado: (2020)

Limited value of long-term biochemical follow-up in patients with adrenal incidentalomas-a retrospective cohort study
por: Yeomans, Hannah, et al.
Publicado: (2015)

Sensitive UHPLC-MS/MS quantification method for 4β- and 4α-hydroxycholesterol in plasma for accurate CYP3A phenotyping
por: Suzuki, Yosuke, et al.
Publicado: (2022)

Response to: “Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time”
por: Kvitne, Kine Eide, et al.
Publicado: (2022)

Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients
por: Holm, Johan, et al.
Publicado: (2020)

Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol
por: Civra, Andrea, et al.
Publicado: (2014)

Adherence to Drug Label Recommendations for Avoiding Drug Interactions Causing Statin-Induced Myopathy–A Nationwide Register Study
por: Settergren, Jennifer, et al.
Publicado: (2013)

Vitamin D, Folic Acid and Vitamin B(12) Can Reverse Vitamin D Deficiency-Induced Learning and Memory Impairment by Altering 27-Hydroxycholesterol and S-Adenosylmethionine
por: Wang, Lijing, et al.
Publicado: (2022)

Postprandial Platelet Activation Is Related to Postprandial Plasma Insulin Rather Than Glucose in Patients With Type 2 Diabetes
por: Spectre, Galia, et al.
Publicado: (2012)

Association between lipid-lowering agents and severe hyponatremia: a population-based case–control study
por: Skov, Jakob, et al.
Publicado: (2020)

Time-dependent association between selective serotonin reuptake inhibitors and hospitalization due to hyponatremia
por: Mannheimer, Buster, et al.
Publicado: (2021)

Reduced risk for hospitalization due to hyponatraemia in lithium treated patients: A Swedish population-based case–control study
por: Falhammar, Henrik, et al.
Publicado: (2020)

Assessment of brain cholesterol metabolism biomarker 24S-hydroxycholesterol in schizophrenia
por: Chiappelli, Joshua, et al.
Publicado: (2020)

Quantitative detection of free 24S-hydroxycholesterol, and 27-hydroxycholesterol from human serum
por: Bandaru, Veera Venkata Ratnam, et al.
Publicado: (2014)

Inhibition of herpes simplex-1 virus replication by 25-hydroxycholesterol and 27-hydroxycholesterol
por: Cagno, Valeria, et al.
Publicado: (2017)

PXR and 4β-Hydroxycholesterol Axis and the Components of Metabolic Syndrome
por: Hukkanen, Janne, et al.
Publicado: (2020)

Serum 4β-hydroxycholesterol increases during fluconazole treatment
por: Lütjohann, Dieter, et al.
Publicado: (2020)

Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients
por: Molanaei, Hadi, et al.
Publicado: (2018)

Tuberculosis of Adrenal Glands—A Population-based Case-control Study
por: Lindh, Jonatan D, et al.
Publicado: (2023)

Inhibition of Marek’s Disease Virus Replication and Spread by 25-hydroxycholesterol and 27-hydroxycholesterol In Vitro
por: Kamble, Nitin, et al.
Publicado: (2023)

miRNA‐27b levels are associated with CYP3A activity in vitro and in vivo
por: Ekström, Lena, et al.
Publicado: (2015)

Prevalence and risk factors for efavirenz-based antiretroviral treatment–associated severe vitamin D deficiency: A prospective cohort study
por: Nylén, Hanna, et al.
Publicado: (2016)

Elevated 4β‐hydroxycholesterol/cholesterol ratio in anorexia nervosa patients
por: Hole, Kristine, et al.
Publicado: (2018)

Associations Between Antihypertensive Medications and Severe Hyponatremia: A Swedish Population–Based Case–Control Study
por: Falhammar, Henrik, et al.
Publicado: (2020)

Sex-specific risks of death in patients hospitalized for hyponatremia: a population-based study
por: Mannheimer, Buster, et al.
Publicado: (2019)

Time-dependent association between omeprazole and esomeprazole and hospitalization due to hyponatremia
por: Issa, Issa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_irecl4h9d4kmrqmfiilq713rm7